March 6, 2007
Illustration: UI researchers have discovered that mutations in FGF signaling pathway genes contribute to cleft lip and palate. The top figure shows the normal sequence for a region of the FGFR1 gene; the bottom figure shows a mutation in the same region for a person with cleft lip and palate.
Additional Genetic Mutations Found That May Cause Cleft Lip/Palate
University of Iowa researchers and collaborators have identified additional genetic mutations that likely cause the common form of cleft lip and palate.
The results could eventually help clinicians predict a family's risk of having more children with the condition. The findings appear the week of March 5 in the online Early Edition of the Proceedings of the National Academy of Sciences.
Cleft lip and palate, found in nearly one of every 700 live births worldwide, occurs when tissues that normally form the lip and palate fail to join early in fetal life. The investigation focused on genes in the fibroblast growth factor (FGF) family, which function in a signaling pathway important in fetal face development, said Bridget Riley (photo, left), a student in the UI Genetics Ph.D. Program and the study's primary author.
"The fibroblast growth factor signaling pathway is interesting because it is involved in many developmental processes, and we were especially interested in how it affects facial development. Prior to this study, the fibroblast growth factors had been looked at in syndromic forms of clefting but had not been examined in non-syndromic forms," said Riley, whose research team is based in the lab of Jeff Murray, M.D., a professor with multiple UI appointments and a study co-author.
The common form of cleft lip and palate is also known as non-syndromic, as it occurs in isolation and not in association with any known syndrome. The team compared the DNA from 184 people from Iowa and the Philippines who had non-syndromic cleft lip and palate with DNA from people without the condition. Riley led the effort that found the mutations in FGF ligands and associated receptors.
Computer modeling of proteins, completed by Moosa Mohammadi, Ph.D., associate professor of pharmacology at New York University School of Medicine, indicated that each mutation would disrupt FGF signaling in a different way. The team will next test the mutant proteins to see if they affect protein function, Riley said.
The researchers estimate that abnormal FGF signaling may account for up to 5 percent of non-syndromic cleft lip and palate cases. Riley emphasized that the findings still need additional study but eventually could have important clinical value through the development of a diagnostic test. The findings could also provide information about FGF signaling in other craniofacial conditions.
"We're now better equipped to look at the factors that cause this birth defect and tackle improved ways to diagnose, treat and, we hope, eventually prevent the condition," said Murray, who is the Roy J. Carver Chair of Prenatal Health and professor of pediatrics in the UI Roy J. and Lucille A. Carver College of Medicine. Murray holds joint appointments in pediatric dentistry in the College of Dentistry, biology in the College of Liberal Arts and Sciences, and epidemiology in the College of Public Health.
Riley initially presented study results in preliminary form at the plenary session of the annual meeting of the American Society of Human Genetics held Oct. 10, 2006, in New Orleans.
The study was supported in part by grants from the National Institute of Dental and Craniofacial Research.
In addition to UI and NYU researchers, the study also involved investigators at the University of Pittsburgh and the Institut Cochin et Laboratoire de Biochimie et Génétique Moléculaire in Paris.
STORY SOURCE: University of Iowa Health Science Relations, 5137 Westlawn, Iowa City, Iowa 52242-1178
MEDIA CONTACT: Becky Soglin, 319-335-6660, email@example.com.